712 related articles for article (PubMed ID: 25940556)
1. The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection.
Storey P; Dollin M; Rayess N; Pitcher J; Reddy S; Vander J; Hsu J; Garg S;
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):235-42. PubMed ID: 25940556
[TBL] [Abstract][Full Text] [Related]
2. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ;
Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453
[TBL] [Abstract][Full Text] [Related]
3. ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics.
Li AL; Wykoff CC; Wang R; Chen E; Benz MS; Fish RH; Wong TP; Major JC; Brown DM; Schefler AC; Kim RY; OʼMalley RE
Retina; 2016 Jul; 36(7):1349-56. PubMed ID: 26655622
[TBL] [Abstract][Full Text] [Related]
4. Acute endophthalmitis after intravitreal injection and preventive effect of preoperative topical antibiotics.
Park Y; Kim KS; Park YH
J Ocul Pharmacol Ther; 2013 Dec; 29(10):900-5. PubMed ID: 24067061
[TBL] [Abstract][Full Text] [Related]
5. Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.
Rayess N; Rahimy E; Storey P; Shah CP; Wolfe JD; Chen E; DeCroos FC; Garg SJ; Hsu J
Am J Ophthalmol; 2016 May; 165():88-93. PubMed ID: 26944277
[TBL] [Abstract][Full Text] [Related]
6. Incidence of endophthalmitis after intravitreal injection with and without topical antibiotic prophylaxis.
Torres-Costa S; Ramos D; Brandão E; Carneiro Â; Rosas V; Rocha-Sousa A; Falcão-Reis F; Falcão M
Eur J Ophthalmol; 2021 Mar; 31(2):600-606. PubMed ID: 32019339
[TBL] [Abstract][Full Text] [Related]
7. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
Bhatt SS; Stepien KE; Joshi K
Retina; 2011 Nov; 31(10):2032-6. PubMed ID: 21659941
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
Storey PP; Tauqeer Z; Yonekawa Y; Todorich B; Wolfe JD; Shah SP; Shah AR; Koto T; Abbey AM; Morizane Y; Sharma P; Wood EH; Morizane-Hosokawa M; Pendri P; Pancholy M; Harkey S; Jeng-Miller KW; Obeid A; Borkar DS; Chen E; Williams P; Okada AA; Inoue M; Shiraga F; Hirakata A; Shah CP; Prenner J; Garg S;
Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics.
Hsu J; Gerstenblith AT; Garg SJ; Vander JF
Am J Ophthalmol; 2014 Mar; 157(3):514-8.e1. PubMed ID: 24332373
[TBL] [Abstract][Full Text] [Related]
12. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.
Dossarps D; Bron AM; Koehrer P; Aho-Glélé LS; Creuzot-Garcher C;
Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127
[TBL] [Abstract][Full Text] [Related]
13. Comparison of endophthalmitis rates following intravitreal injection of compounded bevacizumab, ranibizumab, and aflibercept.
Forooghian F; Albiani DA; Kirker AW; Merkur AB
Can J Ophthalmol; 2017 Dec; 52(6):616-619. PubMed ID: 29217032
[TBL] [Abstract][Full Text] [Related]
14. POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS.
Reibaldi M; Pulvirenti A; Avitabile T; Bonfiglio V; Russo A; Mariotti C; Bucolo C; Mastropasqua R; Parisi G; Longo A
Retina; 2018 Jan; 38(1):1-11. PubMed ID: 28267115
[TBL] [Abstract][Full Text] [Related]
15. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.
Patel SN; Storey PP; Pancholy M; Obeid A; Wibbelsman TD; Levin H; Hsu J; Garg SJ; Dunn JP; Vander JF
Am J Ophthalmol; 2019 Nov; 207():224-231. PubMed ID: 31201794
[TBL] [Abstract][Full Text] [Related]
16. Effect of Topical Antibiotic Prophylaxis on Conjunctival Flora and Antibiotic Resistance Following Intravitreal Injections in Patients with Type 2 Diabetes.
Kaldirim H; Yazgan S; Kirgiz A; Ozdemir B; Yilmaz A
Korean J Ophthalmol; 2020 Aug; 34(4):265-273. PubMed ID: 32783418
[TBL] [Abstract][Full Text] [Related]
17. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
Moshfeghi AA; Rosenfeld PJ; Flynn HW; Schwartz SG; Davis JL; Murray TG; Smiddy WE; Berrocal AM; Dubovy SR; Lee WH; Albini TA; Lalwani GA; Kovach JL; Puliafito CA
Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400
[TBL] [Abstract][Full Text] [Related]
18. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.
Shimada H; Hattori T; Mori R; Nakashizuka H; Fujita K; Yuzawa M
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1885-90. PubMed ID: 23389553
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.
McCannel CA
Retina; 2011 Apr; 31(4):654-61. PubMed ID: 21330939
[TBL] [Abstract][Full Text] [Related]
20. Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review.
Hoevenaars NE; Gans D; Missotten T; van Rooij J; Lesaffre E; van Meurs JC
Ophthalmologica; 2012; 228(3):143-7. PubMed ID: 22796790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
